CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced that
We initiated KemPharm with a Sell rating in March 2021; since then, the stock has declined >40%, and now the stock is trading at an attractive enterprise value of $130m. AZSTARYS targeting ADHD has be
KemPharm, Inc. (NASDAQ:KMPH ) Q3 2022 Results Conference Call November 9, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Travis Mickle - President and Chief
CELEBRATION, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a biotechnology company focused on the discovery, development and commercialization

KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study

03:42pm, Thursday, 29'th Sep 2022 Zacks Investment Research
KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.
KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.

US Stocks Turn Lower; Nasdaq Drops Over 100 Points

04:04pm, Thursday, 15'th Sep 2022 Benzinga
U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday. The Dow traded down 0.12% to 31,099.20 while the NASDAQ fell 1.18% to 11,581.65. T
Upgrades For Nokia Oyj (NYSE:NOK), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the second quarter, Nokia had an EPS of $0.11, compared to year-ago quarter EPS of $0.11. At
CELEBRATION, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and commerci
Wedbush raised the price target on Apple Inc. (NASDAQ: AAPL) from $200 to $220. However, Wedbush analyst Daniel Ives maintained the stock with an Outperform. Apple shares fell 0.2% to $172.69 in pre-
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, August 11, 2022, at 5:00 p.m. ET
KemPharm, Inc. (NASDAQ:KMPH ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President-Investor Relations & Corporate Communications Travis Mick

Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates

09:55pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Journey Medical Corporation (DERM) delivered earnings and revenue surprises of -72% and 13.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc

CTI BioPharma (CTIC) Reports Q2 Loss, Tops Revenue Estimates

10:55pm, Monday, 08'th Aug 2022 Zacks Investment Research
CTI BioPharma (CTIC) delivered earnings and revenue surprises of -5% and 20.87%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Lyell Immunopharma (LYEL) Reports Q2 Loss, Tops Revenue Estimates

10:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Lyell Immunopharma (LYEL) delivered earnings and revenue surprises of 51.61% and 960.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE